These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28077792)

  • 1. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.
    Wu J; Chen M; Liang C; Su W
    Oncotarget; 2017 Feb; 8(8):13400-13412. PubMed ID: 28077792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
    BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
    Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y
    Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies.
    Huang QT; Man QQ; Hu J; Yang YL; Zhang YM; Wang W; Zhong M; Yu YH
    Oncotarget; 2017 Mar; 8(10):16755-16764. PubMed ID: 28187430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
    Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
    Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
    Onal C; Guler OC; Yildirim BA
    Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis.
    Zou P; Yang E; Li Z
    Sci Rep; 2020 Dec; 10(1):21917. PubMed ID: 33318608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
    Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
    World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
    Lu Y; Jiang J; Ren C
    PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Turri-Zanoni M; Salzano G; Lambertoni A; Giovannardi M; Karligkiotis A; Battaglia P; Castelnuovo P
    Head Neck; 2017 Apr; 39(4):730-736. PubMed ID: 28032937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.
    Zhang W; Liu K; Ye B; Liang W; Ren Y
    Cancer Med; 2018 Jan; 7(1):105-113. PubMed ID: 29193777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
    Lee YY; Choi CH; Kim HJ; Kim TJ; Lee JW; Lee JH; Bae DS; Kim BG
    Anticancer Res; 2012 Apr; 32(4):1555-61. PubMed ID: 22493401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis.
    Tan DW; Fu Y; Su Q; Guan MJ; Kong P; Wang SQ; Wang HL
    Sci Rep; 2016 Oct; 6():33789. PubMed ID: 27694951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
    Huang QT; Zhou L; Zeng WJ; Ma QQ; Wang W; Zhong M; Yu YH
    Cell Physiol Biochem; 2017; 41(6):2411-2418. PubMed ID: 28467978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
    Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
    Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
    Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
    Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
    Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
    Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.